Worth reading
30Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
3
LocationWording
Conditional
How definitive the wording is.This transaction
Share AcquisitionDisclosing companyMedical Ikkou Group Co.,Ltd.
TimelineThe spacing between the points is proportional to the actual number of days.White points represent dates designated as scheduled dates in the document.
Target company
Operates 3 dispensing pharmacies, primarily in Nishikyo-ku, Kyoto City
Location Nishikyo-ku, Kyoto City, Kyoto PrefectureDate of incorporation 2000
Impact on Business Performance
The impact of this transaction on the financial results of the Company's group is immaterial.
Procedures and assumptions
Management structure after acquisitionWill become a subsidiary. The trade name, representative and treatment of employees are Not disclosed
| Item | Details |
|---|---|
| Transaction name | Share Acquisition |
| Name of the Subject Company | 株式会社ひまわり薬局 |
| Business Description of the Subject Company | Operates 3 dispensing pharmacies, primarily in Nishikyo-ku, Kyoto City |
| Location of the Subject Company | Nishikyo-ku, Kyoto City, Kyoto Prefecture |
| Date of Establishment of the Subject Company | 2000 |
| Number of shares acquired | All issued shares (the specific number of shares and voting rights is not stated) |
| Voting rights ownership percentage | Acquisition of all issued shares |
| Impact on Business Performance | The impact of this transaction on the financial results of the Company's group is immaterial. |
| Date of board resolution | 25 September 2026 |
| Contract Date | 28 September 2026 (予定) |
| Execution Date / Effective Date | 1 October 2026 (scheduled) |
| Management structure after acquisition | Will become a subsidiary. The trade name, representative and treatment of employees are Not disclosed |
Items this document does not state (20)
Counterparty nameCapital Stock of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Valuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company aims to position the Kyoto area as an important base next to Mie Prefecture, develop a dominant strategy, expand the scale of its dispensing pharmacy business, and thereby enhance corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.